A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 38/21 (2006.01) A61K 9/00 (2006.01) A61K 31/7056 (2006.01) A61P 37/06 (2006.01)
Patent
CA 2649810
The present invention relates to the use of multiple doses of Cladribine combined with beta interferon for the treatment of multiple sclerosis in patients who are refractory to at least one conventional therapy.
La présente invention concerne l'utilisation de multiples doses de Cladribine combinées à l'interféron bêta pour le traitement de la sclérose en plaques chez les patients qui sont réfractaires à au moins une thérapie conventionnelle.
Ammoury Nazih
Brentzel H. James Jr.
Lopez-Bresnahan Maria
Laboratoires Serono S.a.
Mccarthy Tetrault Llp
Merck Serono S.a.
LandOfFree
Cladribine regimen for treating multiple sclerosis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cladribine regimen for treating multiple sclerosis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cladribine regimen for treating multiple sclerosis will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1761992